Zhejiang Hisun Pharmaceutical Co., Ltd.SSE: 600267

Notice on Convening the 1st Extraordinary General Meeting in 2026

· Issued by Zhejiang Hisun Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 6 pages · Chinese

Summary by 6ix AI

The meeting is scheduled for January and will include both onsite and online voting options for shareholders. Shareholders will be able to vote on the proposal to sign a contract for the transfer of a subsidiary's equity. The notice outlines the registration process and voting procedures for shareholders wishing to participate.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Notice on Convening the 1st Extraordinary General Meeting in 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Zhejiang Hisun Pharmaceutical Co., Ltd. on 6ix

Earlier from Zhejiang Hisun Pharmaceutical

Later from Zhejiang Hisun Pharmaceutical

All Zhejiang Hisun Pharmaceutical news releases